Revenue for the fourth quarter of fiscal 2024 was $96.4M versus $101.5 M in fiscal 2023, once again reflecting strength across the company’s key strategic programs – primarily in public health and IT services – offset by certain work converting to small business set-aside contracts, including the one previously-discussed CMOP location. The Company anticipates additional CMOP contract award decisions during fiscal 2025 to eligible small business bidders
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks